Indraprastha Medical Corporation Share Price Target 2026 Analyst Forecast Bull and Bear Case

The Indraprastha Medical Corporation share price target 2026 is Rs 455, based on analyst estimates and the FY27 earnings recovery thesis for Indraprastha Medical Corporation (NSE: INDRAMEDCO). Q4 FY26 results announced May 30, 2026 are the immediate re-rating trigger. This article covers the complete Indraprastha Medical Corporation share price target analysis including sector tailwinds, peer context, key risks, and bull and bear case scenarios.

Click Here – Get Free Investment Predictions

Indraprastha Medical Corporation Share Price Target 2026: Key Takeaways

• Indraprastha Medical Corporation share price target 2026: Rs 455 (20% upside from CMP Rs 379.2)
• Bull case: Rs 550 | Bear case: Rs 305
• Ticker: INDRAMEDCO | Sector: Super-Specialty Hospitals | MCap: Rs 3,034 crore
• 52W range: Rs 239 to Rs 588 | PE: 25x
• Key catalyst: Q4 FY26 results confirming FY27 earnings recovery
• Key risk: FY27 earnings miss or sustained FII outflows

Indraprastha Medical Corporation Company Overview

Indraprastha Medical Corporation (NSE: INDRAMEDCO) is a New Delhi-based Apollo Hospitals subsidiary operating Indraprastha Apollo Hospital on Delhi-Mathura Road, a 710-bed super-specialty tertiary care hospital with FY26 revenue of Rs 2,000 crore growing 18 percent year-on-year. At CMP Rs 379.2 against a 52 week range of Rs 239 to Rs 588, the stock trades at a discount to its 52 week high. Market capitalisation is Rs 3,034 crore with trailing PE of 25x. Compared to peers in hospitals like Fortis Healthcare and Max Healthcare, Indraprastha Medical Corporation is positioned as a potential re-rating candidate toward the Indraprastha Medical Corporation share price target of Rs 455.

Parameter	Value
NSE Ticker	INDRAMEDCO
Sector	Super-Specialty Hospitals
CMP (May 30, 2026)	Rs 379.2
52 Week High	Rs 588
52 Week Low	Rs 239
Market Cap	Rs 3,034 crore
Trailing PE	25x
12-Month Analyst Target	Rs 455
Bull Case Target	Rs 550
Bear Case Target	Rs 305

Why Is the Indraprastha Medical Corporation Share Price Target Set at Rs 455 for 2026

FY27 Earnings Delivery and Revenue Acceleration

The Indraprastha Medical Corporation share price target 2026 of Rs 455 rests on analyst projections of 15 to 20 percent PAT growth in FY27. Q4 FY26 results confirming the earnings recovery trajectory are the most direct catalyst for re-rating from CMP Rs 379.2 toward Rs 455.

Structural Sector Tailwinds in Super-Specialty Hospitals

The Super-Specialty Hospitals sector is expanding on the back of India’s domestic demand growth, PLI scheme support, and rising investment. Indraprastha Medical Corporation’s market position among peers in hospitals like Fortis Healthcare and Max Healthcare creates a structural growth runway supporting the Indraprastha Medical Corporation share price target of Rs 455 and bull case of Rs 550.

RBI Rate Cut Cycle and Lower Cost of Capital

India’s RBI rate cut cycle, commencing early 2026, reduces Indraprastha Medical Corporation’s borrowing costs and stimulates end market demand. Lower interest costs improve EPS trajectory, directly supporting the Indraprastha Medical Corporation share price target of Rs 455.

Union Budget 2026-27 Policy Support

Budget 2026-27’s Rs 11.21 lakh crore infrastructure capex and PLI scheme continuity create a positive policy backdrop for Indraprastha Medical Corporation’s Super-Specialty Hospitals operations, improving the probability of achieving the Indraprastha Medical Corporation share price target of Rs 455.

Improving FII Flows Post the April 2026 Tariff Shock

As global macro conditions normalise post the April 2026 US tariff event, FII flows into quality Indian equities are recovering. At 25x PE, Indraprastha Medical Corporation is positioned as a beneficiary of institutional reallocation toward the Indraprastha Medical Corporation share price target of Rs 455.

Indraprastha Medical Corporation Share Price Targets: Short Term, 12 Month, and Long Term

Short Term Indraprastha Medical Corporation Share Price Target: 3 to 6 Months

The near-term Indraprastha Medical Corporation share price target is anchored to support near the 52 week low of Rs 239. A confirmed Q4 FY26 earnings recovery is the trigger for an initial 10 to 15 percent re-rating toward Rs 455.

12-Month Indraprastha Medical Corporation Share Price Target 2026

The 12-month Indraprastha Medical Corporation share price target 2026 is Rs 455, implying approximately 20 percent upside from CMP Rs 379.2. Track live on NSE ticker INDRAMEDCO.

Long Term Indraprastha Medical Corporation Share Price Target: FY27 to FY28

For investors with a 2 to 3 year horizon, the long-term Indraprastha Medical Corporation share price target is Rs 550 in the bull case, assuming full earnings delivery and sector re-rating among peers in hospitals like Fortis Healthcare and Max Healthcare.

Bull Case and Bear Case for the Indraprastha Medical Corporation Share Price Target

Bull Case Indraprastha Medical Corporation Share Price Target: Rs 550

The bull case of Rs 550 materialises when FY27 earnings beat estimates, Super-Specialty Hospitals tailwinds accelerate, and FII flows return strongly, enabling re-rating toward higher peer multiples.

Bear Case Indraprastha Medical Corporation Share Price Target: Rs 305

The bear case of Rs 305 materialises if FY27 earnings disappoint and FII outflows persist, with the stock approaching the 52 week low of Rs 239.

Scenario	Target	Key Conditions
Bull Case	Rs 550	FY27 earnings beat, re-rating, FII inflows
Base Case	Rs 455	In-line FY27 delivery, partial FII recovery
Bear Case	Rs 305	FY27 miss, guidance cut, FII outflows

Key Risks to the Indraprastha Medical Corporation Share Price Target 2026

US Tariff and Global Macro Risk

Prolonged US tariff tension remains a key macro risk to the Indraprastha Medical Corporation share price target 2026 of Rs 455.

Valuation and Earnings Miss Risk

Any FY27 earnings miss or guidance cut could compress multiples, posing the most direct risk to the Indraprastha Medical Corporation share price target of Rs 455.

Competitive Pressure in Super-Specialty Hospitals

Intensifying competition among peers in hospitals like Fortis Healthcare and Max Healthcare could compress Indraprastha Medical Corporation’s pricing power, a structural risk when evaluating the Indraprastha Medical Corporation share price target of Rs 455.

FII Selling Pressure and Liquidity Risk

Sustained FII outflows can delay re-rating toward the Indraprastha Medical Corporation share price target of Rs 455 regardless of company-level improvement through FY27.

How to Invest in Indraprastha Medical Corporation

Check the Univest Screener for live data

Begin by reviewing Indraprastha Medical Corporation’s Q4 FY26 results, annual report, and FY27 guidance before forming a view on the Indraprastha Medical Corporation share price target of Rs 455. Focus on revenue growth, margin trends, and management commentary on Super-Specialty Hospitals sector opportunities.

Open a Demat and trading account with a SEBI registered stockbroker to buy Indraprastha Medical Corporation (NSE: INDRAMEDCO) with full regulatory protection. Understand the competitive dynamics among peers in hospitals like Fortis Healthcare and Max Healthcare before executing any position.

Plan your entry near the 52 week low support of Rs 239. A confirmed Q4 FY26 earnings uptick and positive FY27 guidance strengthen the entry case for the Indraprastha Medical Corporation share price target of Rs 455. Set a disciplined stop loss below the 52 week low.

Restrict any single stock to 3 to 5 percent of your total equity portfolio to manage concentration risk in the Super-Specialty Hospitals space where sectoral cycles can amplify volatility.

Always consult a SEBI registered financial advisor before investing based on any Indraprastha Medical Corporation share price target estimate. SEBI Registration No. INH000013776.

Download the Univest iOS App or the Univest Android App to track Indraprastha Medical Corporation’s live price and get daily stock recommendations.

FAQs on Indraprastha Medical Corporation Share Price Target 2026

What is the Indraprastha Medical Corporation share price target for 2026?

Ans. The Indraprastha Medical Corporation share price target 2026 is Rs 455, implying approximately 20 percent upside from CMP Rs 379.2. Bull case is Rs 550, bear case is Rs 305.

What is the Indraprastha Medical Corporation share price target for 2025?

Ans. The Indraprastha Medical Corporation share price target for 2025 was based on FY26 earnings projections. The current 2026 analyst target is Rs 455, reflecting FY27 growth potential from CMP Rs 379.2.

Is Indraprastha Medical Corporation a good buy at Rs 379.2?

Ans. At Rs 379.2, Indraprastha Medical Corporation offers potential upside to the share price target of Rs 455 if FY27 earnings recover. Consult a SEBI registered financial advisor before investing.

What is the 52 week high and low of Indraprastha Medical Corporation?

Ans. The 52 week high of Indraprastha Medical Corporation is Rs 588 and the 52 week low is Rs 239. At CMP Rs 379.2, the stock offers upside toward the 12-month share price target of Rs 455.

What are the key risks to the Indraprastha Medical Corporation share price target?

Ans. Key risks include FY27 earnings miss, US tariff-driven FII outflows, competitive pressure among peers in hospitals like Fortis Healthcare and Max Healthcare, and broader market volatility.

What are the catalysts for the Indraprastha Medical Corporation share price target?

Ans. Primary catalysts include FY27 PAT recovery, Super-Specialty Hospitals tailwinds, RBI rate cut support, Budget 2026-27 policy uplift, and FII flow normalisation into Indian equities.

How does Indraprastha Medical Corporation compare to its peers?

Ans. Indraprastha Medical Corporation operates in Super-Specialty Hospitals alongside peers in hospitals like Fortis Healthcare and Max Healthcare. At CMP Rs 379.2 with MCap Rs 3,034 crore, the company is a potential re-rating candidate toward the share price target of Rs 455.

What is the Indraprastha Medical Corporation share price target for 2027?

Ans. The long-term Indraprastha Medical Corporation share price target for FY27 to FY28 is Rs 550 in the bull case, assuming earnings growth, sector re-rating, and FII inflows. Consult a SEBI registered financial advisor for personalised guidance.